Drug Trial Radar · NCT00339014
Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity
Last checked: Nov 20, 2026Latest source record: Apr 22, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
611
Actual
Start
May 2006
Primary completion
Aug 2007
Study completion Aug 2007
Sponsor
- Lead sponsor
- Orexigen Therapeutics, IncIndustry
- Sponsor type
- Industry
- First posted
- Jun 20, 2006
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine which of seven combinations of Zonisamide CR and Bupropion SR gives the best weight loss and is safe and well tolerated for the treatment of obesity not associated with the complications of obesity such as diabetes. In a previous study, the combination of zonisamide and bupropion SR was shown to be effective for weight loss compared to either zonisamide, bupropion SR alone or placebo. It is thought that by adjusting the doses of each drug, giving zonisamide in a controlled release (CR) form and increasing the doses more slowly, more weight loss and less side effects can be attained.
Conditions
- Obesity
Interventions
Zonisamide CR and Bupropion SRDrug
Zonisamide SR and Bupropion SR
PlaceboOther
Identical placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- % change in total body weight as measured between baseline and week 24 (ITT-LOCF analysis)Time frame: Baseline to week 24
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
SelfCenter, PC
Fairhope, Alabama
UCLA Center for Human Nutrition
Los Angeles, California
Scripps Clinic Del Mar
San Diego, California
Center for Human Nutrition University of Colorado Health Sciences Center
Denver, Colorado
George Washington University Weight Management Program
Washington D.C., District of Columbia
CSRA Partners in Health, Inc
Augusta, Georgia
Springfield Diabetes and Endocrine Center
Springfield, Illinois
Pennington Biomedical Research Center
Baton Rouge, Louisiana
Nutrition and Weight Mangement Center Boston Medical Center
Boston, Massachusetts
Center for Nutrition and Metabolic Diseases
Reno, Nevada
Comprehensive Weight Control Program
New York, New York
Center for Nutrition and Preventive Medicine
Charlotte, North Carolina
MUSC Weight Mnagement Center
Charleston, South Carolina
The Cooper Institute
Dallas, Texas
Baylor Endocrine Center
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.